MARKET

 

Cancer: We are actively engaged in supplying life saving oncology drugs to cancer hospitals in Pakistan at subsidized rates, serving the ailing humanity. We at AJM Pharma will try to associate with the  medical community in spreading awareness of this silent killer. By creating awareness in the masses, it will help in early diagnosis which would ultimately lead to better survival of the patients. Our strategy is to hold small public awareness seminars, develop educational booklets for early detection. Our future plan is to develop a platform alongwith Cipla , providing a forum for oncologists around Asia to meet , exchange ideas and listen to presentations of the new research in oncology. Apart from providing High Quality products we will also try to establish a Academic bond with you by providing academic services.

AIDS: We are supplying antiretrovirals to NACP (national aids programme) and CRS (catholic relief services) .We are in constant contact with the NGOs working for aids. World Aids Day 1st December is part of our awareness programme. At the moment we are working on bringing on more awareness about aids, especially in the rural areas. Our main focus is to provide relief to the people already suffering from this dreadful disease by importing High Quality medicines at cheaper rates.

 
   

Thalassaemia: Oral Iron Chelation theraphy is prescribed where infusion is Ineffective or unsuitable. The worlds first oral iron chelator Deferiprone 250/500mg is also being produced by Cipla  by the name of Kelfer. We AJMirza Pharma are bringing Kelfer in Pakistan. We are in constant contact with nearly all the Blood banks in Pakistan. We have even started contacting Haematologists in all the major hospitals in the country. We want to provide High Quality international standards iron chelators to all the thalassaemia centers in the country at reasonable rates.Our thalassaemia team is also part of the ongoing awareness programmes going on in Pakistan. World Thaiassaemia Day is also part of our awareness agenda.